Confusion about Treasury Stock Method when Calculating Diluted Shares Outstanding

Hi all,

Sorry in advance for what is most likely a very basic question.

While the math for calculating diluted shared outstanding is obviously very simple, I'm a bit confused on the logic.

From what I understand, "exercising" an in-the-money option can either mean buying shares at a lower price than market value or selling shares at a higher price than market value, as some options are for buying and some for sale.

So, if the options are exercised by buying shares at a lower price, I understand the logic. For example, if 10,000 shares were bought at a price of $3, and market price is $5, then it would be 10,000 (for all the ones bought) - 6,000 (ones bought back by company) = 4,000 extra shares outstanding. Makes sense to me.

However, if the options are exercised by selling shares. Say, the consumers have options that say they can sell at $8, and the market price is $5. Also assume there exist 10,000 shares in-the-money. Then, the change in shares outstanding would just be 10,000, and the company would be able to buy no more shares because they have already lost $80,000 (no proceeds to put towards purchasing outstanding stock)?

How can the formula be applied to the second situation? Or am I just misunderstanding options (can they only be used to buy)?

EDIT: Question 2:

Why do we not assume that the proceeds from convertible bonds will be used to purchase back outstanding shares, while we do make that assumption for options?

Thank you!

 
Most Helpful

Stock option grants are a way to align employee interests with shareholder interests, In other words, if you do very well, the stock will increase, and you(having received the options) will benefit.

It doesn't' make sense for a company to issue put options, which is what you suggested. That doesn't incentivize. In fact, it could de-incentivize if you already own stock to tank the company, then "put" it back to them at a profit.

 

Omnis earum ratione voluptatibus. Exercitationem doloremque magnam tenetur nemo temporibus. Voluptatem perferendis magnam autem corporis impedit.

Nisi adipisci sed non necessitatibus et. Perferendis dolores quaerat omnis harum.

Aut eveniet reprehenderit id non. Magni dolorem eum modi laudantium.

Career Advancement Opportunities

May 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 04 97.1%

Overall Employee Satisfaction

May 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

May 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

May 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (20) $385
  • Associates (88) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (67) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
CompBanker's picture
CompBanker
98.9
6
dosk17's picture
dosk17
98.9
7
GameTheory's picture
GameTheory
98.9
8
kanon's picture
kanon
98.9
9
DrApeman's picture
DrApeman
98.8
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”